Stine Bjornsen
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The effect of emicizumab and bypassing agents in patients with hemophilia - An in vitro study.
Journal: Research and practice in thrombosis and haemostasis
Published: November 25, 2020
The impact of rivaroxaban on primary hemostasis in patients with venous thrombosis.
Journal: Platelets
Published: December 21, 2018
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban-treated patients in vitro.
Journal: Research and practice in thrombosis and haemostasis
Published: March 01, 2017
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor.
Journal: Thrombosis journal
Published: November 01, 2016
Monitoring bypassing agent therapy - a prospective crossover study comparing thromboelastometry and thrombin generation assay.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: September 21, 2014
Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: October 18, 2013
Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis.
Journal: BMC infectious diseases
Published: January 10, 2012
Thrombin generation and platelet activation related to subintimal percutaneous transluminal angioplasty.
Journal: Scandinavian journal of clinical and laboratory investigation
Published: December 14, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026